Cision PR Newswire

CARsgen Presents First Clinical Data on Its In Vivo CAR-T Product Candidate CT1182

SHANGHAI, Nov. 22, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces the clinical data...

SBTi Verifies GenScript Biotech Corp’s Carbon Emission Reduction Goals, Marking a Major Sustainability Milestone!

PISCATAWAY, N.J., Feb. 18, 2025 /PRNewswire/ -- GenScript Biotech Corp, a global leader in life sciences R&D and manufacturing services, today announced that it...

China’s Technology: From National-Level Products to Breakthroughs in Specialized Fields

BEIJING, Feb. 18, 2025 /PRNewswire/ -- A news report from sinolub: In the era of rapid digitalization and intelligent development, China's technology is...

TigerGPT: Pioneering DeepSeek Integration for AI Chatbot, Upgrading Smart Investment Assistance

SINGAPORE, Feb. 18, 2025 /PRNewswire/ -- Tiger Brokers (NASDAQ: TIGR), a leading online brokerage firm, announces that its AI-powered investment assistant, TigerGPT, has officially integrated...

CJ Bioscience to Present Preclinical Data on Inflammatory Bowel Disease Pipeline Candidate CJRB-201 at ‘ECCO 2025’; Clinical Entry Targeted for 2026

'CJRB-201', a proprietary strain of Faecalibacterium with potent its anti-inflammatory effects, has demonstrated the strongest induction of regulatory T cells (Tregs)...